Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Skowasch

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Pneumologie (Stuttgart, Germany)|October 6, 2025
[Treatment Algorithm of Pulmonary Arterial Hypertension]Ekkehard Grünig, Katrin Milger, Albert Omlor, et al.
BMC Cancer|April 30, 2020
Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcomeMarius Freytag, Ulrich Herrlinger, Stefan Hauser, et al.
ESC Heart Failure|March 4, 2025
Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysisDirk Skowasch, Christine Pausch, Doerte Huscher, et al.
ERJ Open Research|December 10, 2025
Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat <i>versus</i> other medications: a COMPERA analysisMatthias Held, Christine Pausch, Doerte Huscher, et al.
BMJ Open|December 17, 2021
Bronchial Thermoplasty Global Registry (BTGR): 2-year resultsAlfons Torrego, Felix J Herth, Ana M Munoz-Fernandez, et al.
Respiratory Research|March 6, 2024
Disease trajectories in interstitial lung diseases - data from the EXCITING-ILD registryKatharina Buschulte, Hans-Joachim Kabitz, Lars Hagmeyer, et al.
The European Respiratory Journal|May 9, 2020
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registryJürgen Behr, Antje Prasse, Hubert Wirtz, et al.
BMJ Open Respiratory Research|December 25, 2025
Baseline characteristics from the EXCITING-ILD registryKatharina Buschulte, Hans-Joachim Kabitz, Lars Hagmeyer, et al.
Respiratory Research|January 4, 2024
Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registryKatharina Buschulte, Hans-Joachim Kabitz, Lars Hagmeyer, et al.
American Journal of Respiratory and Critical Care Medicine|August 13, 2019
Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical TrialDirk-Jan Slebos, Pallav L Shah, Felix J F Herth, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Pneumologie (Stuttgart, Germany)|October 6, 2025
[Treatment Algorithm of Pulmonary Arterial Hypertension]Ekkehard Grünig, Katrin Milger, Albert Omlor, et al.
BMC Cancer|April 30, 2020
Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcomeMarius Freytag, Ulrich Herrlinger, Stefan Hauser, et al.
ESC Heart Failure|March 4, 2025
Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysisDirk Skowasch, Christine Pausch, Doerte Huscher, et al.
ERJ Open Research|December 10, 2025
Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat <i>versus</i> other medications: a COMPERA analysisMatthias Held, Christine Pausch, Doerte Huscher, et al.
BMJ Open|December 17, 2021
Bronchial Thermoplasty Global Registry (BTGR): 2-year resultsAlfons Torrego, Felix J Herth, Ana M Munoz-Fernandez, et al.
Respiratory Research|March 6, 2024
Disease trajectories in interstitial lung diseases - data from the EXCITING-ILD registryKatharina Buschulte, Hans-Joachim Kabitz, Lars Hagmeyer, et al.
The European Respiratory Journal|May 9, 2020
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registryJürgen Behr, Antje Prasse, Hubert Wirtz, et al.
BMJ Open Respiratory Research|December 25, 2025
Baseline characteristics from the EXCITING-ILD registryKatharina Buschulte, Hans-Joachim Kabitz, Lars Hagmeyer, et al.
Respiratory Research|January 4, 2024
Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registryKatharina Buschulte, Hans-Joachim Kabitz, Lars Hagmeyer, et al.
American Journal of Respiratory and Critical Care Medicine|August 13, 2019
Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical TrialDirk-Jan Slebos, Pallav L Shah, Felix J F Herth, et al.
Pageof 19